Designed to give biologists unprecedented control over lab equipment, Synthace has raised $25.6M in Series B funding led by Horizons Ventures and including SOSV and Luminous Ventures. Synthace was founded by Markus Gershater and Sean Ward in 2011, and it has now raised a total of $45.2M throughout seven rounds.
Page 10 of 15
